title: Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
abstract: The stress-related neuropeptide, corticotropin-releasing factor (CRF) regulates the dorsal raphe nucleus-serotonin (DRN-5-HT) system during stress and this may underlie affective and cognitive dysfunctions that characterize stress-related psychiatric disorders. CRF acts on both CRF1 and CRF2 receptor subtypes in the DRN that exert opposing inhibitory and excitatory effects on DRN-5-HT neuronal activity and 5-HT forebrain release, respectively. The current study first assessed the cognitive effects of intra-DRN microinfusion of CRF or the selective CRF2 agonist, urocortin II in stress-naive rats on performance of an operant strategy set-shifting task that is mediated by the medial prefrontal cortex (mPFC). CRF (30 ng) facilitated strategy set-shifting performance, whereas higher doses of CRF and urocortin II that would interact with CRF2 were without effect, consistent with a CRF1-mediated action. This dose decreased 5-HT extracellular levels in the mPFC, further supporting a role for CRF1. The effects of CRF were then assessed in rats exposed to repeated social stress using the resident-intruder model. Repeated social stress shifted the CRF effect from facilitation of strategy set shifting to facilitation of reversal learning and this was most prominent in a subpopulation of rats that resist defeat. Notably, in this subpopulation of rats 5-HT neuronal responses to CRF have been demonstrated to shift from CRF1-mediated inhibition to CRF2-mediated excitation. Because 5-HT facilitates reversal learning, the present results suggest that stress-induced changes in the cellular effects of CRF in the DRN translate to changes in cognitive effects of CRF. Together, the results underscore the potential for stress history to shift cognitive processing through changes in CRF neurotransmission in the DRN and the association of this effect with coping strategy.
authors: Neuroscience Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.
authors: Kevin P
authors: KP
authors: Snyder
authors: Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
authors: Tiffany E
authors: TE
authors: Hill-Smith
authors: Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.|Department of Pharmacology, University of Pennsylvania, Philadelphia, PA, USA.
authors: Irwin
authors: I
authors: Lucki
authors: Department of Anesthesiology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
authors: Rita J
authors: RJ
authors: Valentino
mesh_terms: D000223:Adaptation, Psychological / Q000187:drug effects / Q000502:physiology; D000818:Animals; D002491:Central Nervous System Agents / Q000008:administration & dosage; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000378:metabolism*; D004291:Dominance-Subordination; D004298:Dopamine / Q000378:metabolism; D065847:Dorsal Raphe Nucleus / Q000187:drug effects / Q000378:metabolism*; D056344:Executive Function / Q000187:drug effects / Q000502:physiology*; D008297:Male; D020318:Rats, Long-Evans; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000819:agonists / Q000378:metabolism; D012193:Reversal Learning / Q000187:drug effects / Q000502:physiology*; D012701:Serotonin / Q000378:metabolism; D013315:Stress, Psychological / Q000378:metabolism*; D054832:Urocortins / Q000008:administration & dosage / Q000378:metabolism
chemical_list: C101531:CRF receptor type 2; D002491:Central Nervous System Agents; D018019:Receptors, Corticotropin-Releasing Hormone; D054832:Urocortins; D012701:Serotonin; D003346:Corticotropin-Releasing Hormone; D004298:Dopamine